cap polyposis
ORPHA: 1601481 Treatment Available
Overview
Cap polyposis (CP) is a rare colorectal disease characterized by multiple inflammatory polyps that predominantly affect the rectosigmoid area and that manifests primarily as rectal bleeding with abnormal transit, constipation and diarrhea
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Metronidazole | Oral tablets 250mg, 500mg; IV infusion 5mg/mL | FDA Approved | 7 | 3d |
Clinical Presentation
Signs and symptoms associated with cap polyposis, sourced from HPO and Orphanet clinical annotations.
Colorectal polyposisConstipationAbdominal painHematocheziaAtrophic gastritisWeight lossDiarrheaAbdominal distention
Classification & Codes
Orphanet Code
ORPHA:160148cap polyposis
| Orphanet | ORPHA:160148 |
| Treatments | 1 drug(s) |
| Symptoms on record | 8 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO